Dacoma Farmers Coop

With a market cap of $385.8 billion, The Coca-Cola Company (KO) is a global beverage leader with brands sold across more than 200 countries and territories, serving about 2.2 billion drinks every day. Its portfolio spans sparkling soft drinks, water, sports drinks, coffee, tea, juice, dairy and plant-based beverages, including 32 billion-dollar brands. Companies valued at more than $200 billion are generally considered “mega-cap” stocks, and Coca-Cola fits this criterion perfectly.

With a market cap of $521.5 billion, Mastercard Incorporated (MA) is a global payments technology company operating across more than 220 countries and territories. It enables secure, simple, smart and accessible digital payments through its technology, network and broad range of products and services. Companies worth more than $200 billion are generally labeled as “mega-cap” stocks and Mastercard Incorporated fits this criterion perfectly.

With a market cap of $352.7 billion, UnitedHealth Group Incorporated (UNH) is a diversified health care company operating globally through four main segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. Its businesses provide health benefit plans, care delivery, data and technology services, and pharmacy care solutions to individuals, employers, government programs, and health systems.

Apple (AAPL) just made a strong move to improve its AI reputation. The company spent two years being seen as a step behind in AI, yet it has quietly become the first to introduce a 2nm chip. Its new M6, built on TSMC’s (TSM) most advanced 2nm process, is the first of its kind in a consumer computer. The chip debuts in a new Mac mini, alongside a more powerful M5 Ultra in the refreshed Mac Studio.

Shares of Elon Musk's space company SpaceX (SPCX) have been on a roll since its IPO. It just so happens that the roll has mostly been downwards, which was expected after a bumper initial burst. Among the few noticeable concerns raised by the naysayers, the increase in capex has been acting as a headwind against SPCX stock. Well, the proposed $100 billion starship complex in Louisiana is the company's way of messaging that there will be no slowdown in capex spend.

AMD (AMD) just hit a milestone that would have seemed unlikely a few years ago. For the first time, it controls more than 30% of the market for x86 client CPUs, the chips that run desktops and laptops. According to Mercury Research, AMD’s share reached 30.3% in the second quarter, up from just 21.1% two years ago. Intel (INTC) still holds the rest at 69.7%, but that share has been dropping lately. AMD gained ground in desktops, laptops, and servers all at once.

Microsoft (MSFT) and Oracle (ORCL) are both legacy tech giants, but when the AI boom took off, Microsoft had the clearer advantage. Azure already had enormous scale, and Microsoft’s partnership with OpenAI gave it an early strategic advantage in the race. Oracle, meanwhile, looked like the one trying to catch up. But Oracle’s position quickly changed. Oracle is rapidly expanding its AI infrastructure business, winning major contracts and emerging as an unexpected underdog in the AI cloud battle.

Alphabet (GOOG) (GOOGL) stock has delivered a relatively modest gain of about 8% year-to-date (YTD), trailing the broader S&P 500's ($SPX) 12.7%. However, the stock’s muted performance does not reflect the business's underlying strength. Alphabet continues to expand its core operations while accelerating its investment in artificial intelligence (AI), creating catalysts for solid growth and a move toward new all-time highs. 1.

With a market cap of $649.6 billion, ExxonMobil Holdings Corporation (XOM) is one of the world’s largest integrated energy companies, with leading upstream oil and gas assets, the largest global refining operations, and substantial chemical businesses. Known for disciplined capital allocation and industry-leading returns, the company maintains a strong dividend record and credit profile.

New Brunswick, New Jersey-based Johnson & Johnson (JNJ) is a diversified global healthcare giant with operations spanning prescription medicines and medical technology. Valued at a market cap of $640.5 billion, the company operates through two core segments: Innovative Medicine and MedTech.